SIA
GSK icon

Strategic Investment Advisors’s GSK GSK Stock Holding History

Strategic Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,379
Closed -$206K – 197
2020
Q3 		$206K Sell
4,379
-4,158
-49% -$208K 0.07% 171
2020
Q2 		$435K Sell
8,537
-527
-6% -$27K 0.16% 98
2020
Q1 		$429K Buy
9,064
+147
+2% +$7.84K 0.2% 89
2019
Q4 		$524K Buy
8,917
+257
+3% +$14.3K 0.22% 83
2019
Q3 		$462K Buy
8,660
+626
+8% +$32.2K 0.22% 76
2019
Q2 		$402K Buy
8,034
+800
+11% +$40.1K 0.22% 78
2019
Q1 		$378K Buy
7,234
+308
+4% +$15.4K 0.26% 75
2018
Q4 		$331K Buy
+6,926
New +$341K 0.3% 73

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Strategic Investment Advisors's GSK Position: Q4 2020 in Review

Strategic Investment Advisors sold out of GSK (GSK) in Q4 2020, closing a stake of 4,379 shares — an estimated $206K sold.

Strategic Investment Advisors first reported a position in GSK in Q4 2018 and held it in 8 quarters. The position peaked at $524K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Strategic Investment Advisors reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Strategic Investment Advisors sold 4,379 GSK shares in Q4 2020, an estimated $206K.
  • Strategic Investment Advisors first reported a position in GSK in Q4 2018 and held it in 8 quarters.
  • Strategic Investment Advisors's GSK position peaked at $524K in Q4 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Strategic Investment Advisors's 13F filing for Q4 2020, filed 13 Jan 2021.